ERROL HOOK: Open Payments
NPI 1225017445 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,840 in 89 payments from 17 companies in 2025. Trend: 2023 $1,940 · 2024 $1,777 · 2025 $1,840
Food & beverage: $1,840
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 23 | $489 |
| Avadel CNS Pharmaceuticals, LLC | 9 | $228 |
| HARMONY BIOSCIENCES LLC | 7 | $173 |
| Regeneron Healthcare Solutions, Inc. | 7 | $164 |
| GlaxoSmithKline, LLC. | 8 | $152 |
| GENZYME CORPORATION | 5 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $98 |
| Amgen Inc. | 5 | $81 |
| Genentech USA, Inc. | 3 | $64 |
| Lilly USA, LLC | 4 | $64 |
Products named: DUPIXENT, LUMRYZ, AIRSUPRA, TEZSPIRE, WAKIX, FASENRA, NUCALA, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
